Carpal Tunnel Syndrome
Conditions
Brief summary
Successful treatment outcome after one year, defined as attainment of Boston Carpal Tunnel Questionnaire Symptom Score ≤ 1.5
Detailed description
Successful treatment result (as defined above) after 3, 6 and 24 months, Successful treatment result after one injection, and after two injections, Patients in the injection arm who have undergone surgery after 3 weeks, 3, 6, 12 and 24 months, Work performance/participation and health care utilization as outlined in section 8.8 at each, or a combination, of time points., Adverse events throughout the study, Patient-reported measures of symptoms and function, ultrasound and NCS measures as outlined in section 8.1 at each time point, Emitted CO2-equivalents per treatment strategy pathway.
Interventions
DRUGinjeksjonsvæske
DRUGsuspensjon
DRUGTrica 20 mg/ml injeksjonsvæske
DRUGLederspan 20 mg/ml injeksjonsvæske
DRUGsuspensjon.
Sponsors
Diakonhjemmet Sykehus AS
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful treatment outcome after one year, defined as attainment of Boston Carpal Tunnel Questionnaire Symptom Score ≤ 1.5 | — |
Secondary
| Measure | Time frame |
|---|---|
| Successful treatment result (as defined above) after 3, 6 and 24 months, Successful treatment result after one injection, and after two injections, Patients in the injection arm who have undergone surgery after 3 weeks, 3, 6, 12 and 24 months, Work performance/participation and health care utilization as outlined in section 8.8 at each, or a combination, of time points., Adverse events throughout the study, Patient-reported measures of symptoms and function, ultrasound and NCS measures as outlined in section 8.1 at each time point, Emitted CO2-equivalents per treatment strategy pathway. | — |
Countries
Norway
Outcome results
None listed